Atlas Trials

A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma

Clinical trial NCT04900792 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04900792
Sponsor
Bryan Allen
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
GlioblastomaGlioblastoma Multiforme
Start date
2023-02-28
Primary completion
2025-05-13
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.